Peripheral Vascular Diseases Clinical Trial
Official title:
Comparison of Primary Patency Between GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts
Verified date | August 2008 |
Source | W.L.Gore & Associates |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
To demonstrate equivalence in patency performance of GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts in a peripheral bypass application to support a claim of substantial equivalence.
Status | Completed |
Enrollment | 200 |
Est. completion date | August 2007 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Patient requires primary above-knee bypass where the proximal anastomosis will be to the common femoral or proximal superficial femoral artery and the distal anastomosis will be the popliteal artery proximal to the medial head of the gastrocnemius; - Patient has Grade III or IV occlusive vascular disease; - Patient has a postoperative life expectancy greater than one year; - Patient is at least 21 years of age; - Patient is able to comply with all study requirements and be available for follow-up visits at 1 month, 6 months and 12 months post procedure; - Patient is willing and able to provide written, informed consent. Exclusion Criteria: - Patient had a previous bypass in the diseased extremity (below iliacs); - Patient has known coagulation disorders including hypercoagulability; - Patient has had any previous instance of Heparin Induced Thrombocytopenia type 2 (HIT-2) or has known hypersensitivity to heparin; - Patient has an acute embolic arterial occlusion; - Patient requires sequential extremity revascularizations or other procedures that require use of additional vascular grafts; - Patient had percutaneous transluminal angioplasty to the implant site within the previous 30 days; - Patient is in need of, or is scheduled for, a cardiac surgical procedure or a different vascular surgical procedure; - Patient has active infection in the region of graft placement; or - Patient has an incomplete preoperative assessment (as outlined in this protocol) due to an emergency procedure, a traumatic injury or any other reason. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Upper Chesapeake Medical Center | Baltimore | Maryland |
United States | William Beaumont Hospital | Bingham Farms | Michigan |
United States | Maimonides Hospital | Brooklyn | New York |
United States | Charleston Area Medical Center | Charleston | West Virginia |
United States | Ohio State University Medical Center | Columbus | Ohio |
United States | Memorial Regional Hospital | Hollywood | Florida |
United States | University of Mississippi Medical Center | Jackson | Mississippi |
United States | St. Vincent's Hospital | Jacksonville | Florida |
United States | Borgess Hospital | Kalamazoo | Michigan |
United States | Jewish Hospital | Louisville | Kentucky |
United States | Medical Center of Central Georgia | Macon | Georgia |
United States | Baptist East Hospital | Memphis | Tennessee |
United States | Morristown Memorial Hospital | Morristown | New Jersey |
United States | Sacred Heart Hospital | Pensacola | Florida |
United States | Wilkes-Barre General Hospital | Plains | Pennsylvania |
United States | Baystate Medical Center | Springfield | Massachusetts |
United States | Mercy Medical Center | Springfield | Massachusetts |
United States | Georgetown University Hospital | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
W.L.Gore & Associates |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary patency at 12 months | |||
Primary | Major device complication rates at 12 months | |||
Secondary | Technical failures | |||
Secondary | Secondary patency |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT00536796 -
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
|
N/A | |
Completed |
NCT00371371 -
Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)
|
Phase 1/Phase 2 | |
Recruiting |
NCT00173602 -
The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT00228384 -
GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study
|
Phase 4 | |
Completed |
NCT00163267 -
Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel
|
Phase 2/Phase 3 | |
Completed |
NCT00106327 -
Improving Functioning in Peripheral Arterial Disease
|
N/A | |
Completed |
NCT00049907 -
Cardiac and Renal Disease Study (CARDS)
|
N/A | |
Completed |
NCT00000614 -
Prevention of Recurrent Venous Thromboembolism (PREVENT)
|
Phase 3 | |
Completed |
NCT00005392 -
Epidemiology of Venous Disease
|
N/A | |
Recruiting |
NCT05596760 -
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
|
N/A | |
Recruiting |
NCT00539266 -
Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia
|
Phase 2/Phase 3 | |
Completed |
NCT00541307 -
GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)
|
N/A | |
Completed |
NCT00520312 -
Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease
|
N/A | |
Terminated |
NCT00504088 -
Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
|
Phase 4 | |
Completed |
NCT00533104 -
Cell Therapy in Chronic Limb Ischemia
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT05459818 -
Individual Patient Data Analysis of Viabahn for Peripheral Arterial Disease
|
||
Completed |
NCT03875846 -
Intraoperative Simultaneous Pressure Guided Revascularization Study
|
||
Active, not recruiting |
NCT05110677 -
Pilot Study of Topographic Imaging of the Calf Muscle in Patients With PAD Using 3D Reconstruction of MSOT Images
|
||
Active, not recruiting |
NCT02856230 -
An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)
|
Phase 2/Phase 3 |